Best Brain Tumor Hospital in Hyderabad — 11 Centres, NCCN Protocols, NABH-Accredited Partners

Brain tumor surgery should be performed by a neurosurgeon with specific brain tumor expertise — sometimes called a neurosurgical oncologist. This is a different focus from general neurosurgery (which also covers spine surgery, trauma, and other neurological conditions). Around the lead surgeon, the team needs a neuro-oncologist (a medical oncologist with specific training in brain tumors), a radiation oncologist trained in both external beam radiation and stereotactic radiosurgery, a neuropathologist who interprets brain tumor tissue and the molecular markers that guide modern treatment, a neuroradiologist for interpreting imaging, and a neuro-rehabilitation team (physiotherapist, occupational therapist, speech and language therapist, neuropsychologist). For pituitary tumors, an endocrinologist is also part of the team.

Walk away if the surgery is being performed by a general neurosurgeon without documented brain tumor experience.

A brain tumor tumour board reviews the MRI, the biopsy (if one was needed for diagnosis), the molecular features of the tumor, and the patient's overall neurological state. The board's central question is: how much of this tumor can be safely removed, and what approach gives the best chance of removal while preserving brain function? For glioma surgery in particular, extent of resection directly affects outcomes — more complete removal generally means better survival. But over-aggressive surgery can cause permanent neurological damage. The tumour board balances these factors.

Walk away if surgery is being scheduled without documented multidisciplinary discussion of how much of the tumor can be safely removed.

Brain tumor surgery has a strong volume-outcome relationship. The team's experience with the specific tumor location matters — tumors near speech areas, motor areas, or vision areas all require different approaches. For tumors in critical brain function areas (called 'eloquent areas'), awake craniotomy with intraoperative brain mapping is the gold standard: the patient is sedated for the opening and closing parts of the operation but awake during tumor removal, while the team gently stimulates different brain areas to map which are safe to operate on and which control critical functions. This requires specialised training across the entire team — surgeon, anaesthetist, neuropsychologist. Ask: 'How many brain tumor surgeries did your team perform last year? How many awake craniotomies?'

Walk away if the team cannot quote specific annual numbers or doesn't offer awake craniotomy when the tumor location requires it.

Brain tumor diagnosis starts with MRI of the brain with contrast — the workhorse imaging test. For surgical planning, functional MRI (which shows which brain areas are active during specific tasks) and diffusion imaging (which shows the white matter tracts that connect brain areas) help the surgeon plan a safe approach. MR spectroscopy can help distinguish tumor from other conditions. Once tissue is obtained — either via biopsy or during surgery — the pathologist examines the cells and tests for specific molecular markers that drive modern treatment decisions. For gliomas, the key markers include IDH mutation status, MGMT methylation, and (for oligodendrogliomas) 1p/19q codeletion. These results affect everything from whether chemotherapy is added to whether targeted therapy is appropriate.

Walk away if the hospital does not perform molecular testing on glioma tissue routinely.

Stereotactic radiosurgery is a non-surgical treatment that delivers a high, focused dose of radiation to a small, precisely defined target — without opening the skull. Despite the name, no actual surgery is involved. The two main systems are Gamma Knife (which uses cobalt radiation sources arranged around the head) and CyberKnife (which uses a robotic arm to deliver radiation from many angles). Stereotactic radiosurgery is the preferred treatment for many brain metastases (especially 1–4 lesions), for small acoustic neuromas, for residual tumor after surgery, and for selected meningiomas. Most treatments are delivered in 1–5 sessions with same-day or next-day discharge. Not every hospital offers stereotactic radiosurgery. Ask: 'If radiosurgery is appropriate for my case, where will it be done?'

Walk away if the hospital cannot offer stereotactic radiosurgery through a partner pathway.

Brain tumor surgery requires a specialised operating theatre with intraoperative imaging capability where possible, a neurosurgical intensive care unit for the immediate post-operative period, and a team experienced with the specific anatomical challenges of brain surgery. Stereotactic radiosurgery requires either a Gamma Knife or CyberKnife system, both of which require specialised facilities. NABH-accredited partners signal audited surgical, anaesthetic, infection-control, and radiation-safety standards.

Walk away if the hospital cannot name the partner facility for neurosurgery and radiosurgery.

Brain tumor treatment is a significant financial commitment — surgery, radiation (especially stereotactic radiosurgery, which is expensive), chemotherapy with temozolomide for glioblastoma, and (for recurrent disease) targeted therapy with bevacizumab all add up. Neuro-rehabilitation continues for months. A hospital that isn't empanelled for your insurance or ArogyaSri at the specific centre where your treatment happens can derail planning.

Walk away if cost estimates change after admission — a serious hospital writes them down beforehand.

Brain tumor treatment can affect movement, speech, language, vision, cognition, memory, and emotional regulation — depending on which part of the brain was involved and what treatment was needed. Neuro-rehabilitation is a structured, multi-disciplinary process: physiotherapy for movement and balance, occupational therapy for daily activities, speech and language therapy when communication is affected, neuropsychology assessment and cognitive rehabilitation, and emotional and psychological support. For patients whose work or driving has been affected, return-to-activity counselling matters. For families, support and education about what to expect (which often changes over time) matters. Rehabilitation often continues for months after treatment.

Walk away if the hospital does not name neuro-rehabilitation and cognitive support services as part of the standard care pathway.

Hospital infrastructure for brain tumor is tiered at CION. MRI staging, biopsy coordination, day-care chemotherapy, post-surgery follow-up, structured neuro-rehabilitation (physiotherapy, occupational therapy, speech therapy, cognitive rehabilitation), and routine surveillance happen at the centre nearest your home. Craniotomy with maximum safe resection, awake craniotomy with brain mapping, stereotactic radiosurgery, and complex skull base or pituitary surgery run through NABH-accredited partner hospitals with verified neurosurgical expertise. The same oncology team that consults at one centre stays with you across the network.

Brain tumors range from benign meningiomas with excellent outcomes to glioblastoma, where even modern treatment achieves only modest survival improvements. CION discusses prognosis honestly — neither falsely reassuring nor unnecessarily bleak. For benign tumors (most meningiomas, pituitary tumors, schwannomas), the focus is often on whether treatment is needed at all versus structured observation. For low-grade gliomas, the focus is on long-term outcomes with appropriate surgery and follow-up. For high-grade gliomas including glioblastoma, the focus is on maximising the benefit from each available treatment while supporting the patient and family through what is genuinely a difficult journey. For brain metastases, the focus is coordination with the primary cancer team to optimise both brain-directed and systemic treatment.

MRI of the brain with contrast is available across six CION centres in Hyderabad. For surgical planning, functional MRI and diffusion imaging are coordinated through partner radiology. For glioma cases, the tissue obtained during biopsy or surgery is sent for routine molecular testing including IDH mutation status, MGMT methylation, and (for relevant tumor types) 1p/19q codeletion — these results directly affect treatment decisions and prognosis. For metastatic brain disease, primary tumor evaluation is coordinated with CION's existing pathways for lung, breast, melanoma, kidney, and other primary cancers.

Where a tumor is located in or near critical brain function areas (speech, motor, vision), CION coordinates awake craniotomy with intraoperative brain mapping through partner neurosurgical centres. The patient is sedated and pain-free during opening and closing of the operation but awake during tumor removal — speaking, moving, and responding while the surgeon gently stimulates different brain areas to identify which are safe to operate on and which control critical functions. This is a specialised procedure requiring trained surgeons, anaesthetists, and neuropsychologists working together.

For brain metastases (1–4 lesions), small acoustic neuromas, selected meningiomas, residual tumor after surgery, and other appropriate indications, stereotactic radiosurgery via Gamma Knife or CyberKnife is coordinated through NABH-accredited partner radiation centres. Most patients receive treatment in 1–5 sessions and go home the same day. For the right indication, radiosurgery can be remarkably effective with minimal disruption to the patient's life.

All 11 CION centres in Hyderabad have day-care infusion bays. Temozolomide for glioblastoma (given orally with radiation and then for several months after), bevacizumab for recurrent glioblastoma, and emerging targeted therapies based on molecular features are administered close to home. Oncology-trained nursing experienced with managing chemotherapy side effects, infusion-reaction protocols, and on-site oncologist supervision are standard at every centre.

Brain tumor recovery is not just about surgery and radiation — it is also about regaining function. CION integrates neuro-rehabilitation as a core part of the care pathway. Physiotherapy for movement and balance, occupational therapy for daily activities, speech and language therapy where communication is affected, neuropsychology assessment and cognitive rehabilitation where memory or attention is affected, return-to-work counselling, and family education and support are all part of the standard pathway. Rehabilitation continues for as long as it helps.

Every brain tumor case at CION is reviewed by the multidisciplinary tumour board before the treatment plan is finalised. The board reviews the MRI and any functional imaging, the biopsy and molecular results where available, the patient's neurological state and overall health; debates the surgical approach including whether awake craniotomy is needed; plans the role of radiation (external beam vs stereotactic radiosurgery) and chemotherapy; coordinates rehabilitation; and plans surveillance imaging schedule. The board produces a written summary that becomes part of your records — and yours to keep. You can take it to any second opinion, anywhere.